Recently, SLC16A1 has been shown to be upregulated in HNSCC tumour tissues compared to adjacent normal marginal tissues, emphasising its potential oncogenic role in cancer progression likely through the NF-κB pathway [45]. The gene discussed is SLC16A1; the disease is head and neck squamous cell carcinoma.